STRATTERA is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents and adults (See Pharmacology: Pharmacodynamics under Actions). Diagnosis should be made according to DSM-IV criteria or the guidelines in ICD-10.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Manage Account
Change Password
Sign Out
